Final 3-year results from the EVIDENS study, an observational study of nivolumab in non-small cell lung cancer
{{output}}
EVIDENS was a prospective, non-interventional, longitudinal study conducted in non-small cell lung cancer (NSCLC) patients receiving nivolumab in France. It recruited adults with pathologically confirmed NSCLC who initiated nivolumab between October 2016 and N... ...
